Health Systems and Policy Monitor (HSPM)

An innovative platform that provides a detailed description of health systems and provides up-to-date information on reforms and changes that are particularly policy relevant.
For detailed information on country policy responses to the COVID-19 pandemic during 2020-2021, see our separate COVID-19 Health Systems Response Monitor (HSRM).

obs-logo

Updates

Changes in reimbursement for cervical cancer screening

27 January 2025 | Country Update

Until now, the Belgian population aged between 25 and 65 has had access to cervical cancer screening through a Pap smear test every three years. From January 2025, women aged 25 to 29 will continue to have a Pap smear test every three years, while for women aged 30 to 64, the primary screening method will be a human papillomavirus (HPV) test every five years. This test detects HPV through a cervical smear before the presence of lesions become detectable by cytology. The screening schedule is uniform across Belgium, but its organization varies by federated entities. In the Flemish community, screening is systematically offered free of charge through an organized program. In other communities, screening is reimbursed but is not yet systematic, as no organized screening program is in place.
References
NIHDI (2025). Cervical cancer detection in Belgium: Introduction of HPV testing as a primaryscreening test [in French]. Brussels: National Institute for Health and Disability Insurance Détection du cancer du col de l’utérus en Belgique : Introduction du test HPV comme test de dépistage primaire|INAMI, accessed 24 January 2025)

Subscribe to our newsletter

Sign Up